Company

Last deal

$5.M

Amount

Pre-Seed

Stage

19.03.2024

Date

all rounds

$5.M

Total amount

Portal is a cell engineering platform company.

Also Known As

Portal Biotechnologies

founded date

2023

Number of employees

Last funding type

Pre-Seed

IPO status

Private

Description

Portal is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings.

location

Website URL

Social url